We are live on ! Find out more
Man Group

Man Group Portfolio holdings

AUM $55.1B
1-Year Est. Return 24.23%
This Fund
S&P 500
This Quarter Est. Return
+2.61%
1 Year Est. Return
+24.23%
3 Year Est. Return
+82.67%
5 Year Est. Return
+105.49%
10 Year Est. Return
AUM
$39.6B
AUM Growth
-$67.3M
Cap. Flow
-$1.56B
Cap. Flow %
-3.93%
Top 10 Hldgs %
14.94%
Holding
2,343
New
235
Increased
870
Reduced
773
Closed
343

Top Sells

Rank Stock Value
1
TSM icon
TSMC
TSM
+$343M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$144M
3
DT icon
Dynatrace
DT
+$135M
4
NDAQ icon
Nasdaq
NDAQ
+$129M
5
BKNG icon
Booking.com
BKNG
+$125M

Sector Composition

Rank Sector Weight
1 Technology 23.36%
2 Consumer Discretionary 12.08%
3 Healthcare 11.86%
4 Financials 10.83%
5 Industrials 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FUL icon
1676
H.B. Fuller
FUL
$3B
$295K ﹤0.01%
+3,837
New +$299K
SMID icon
1677
Smith-Midland
SMID
$161M
$295K ﹤0.01%
10,654
-5,765
-35% -$211K
NNBR icon
1678
NN Inc
NNBR
$272M
$295K ﹤0.01%
98,315
-2,142
-2% -$7.5K
RCL icon
1679
Royal Caribbean
RCL
$78.7B
$292K ﹤0.01%
1,832
-130,171
-99% -$18.7M
GTHX
1680
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$291K ﹤0.01%
127,723
-147,635
-54% -$564K
NPCE icon
1681
Neuropace
NPCE
$505M
$291K ﹤0.01%
38,470
+528
+1% +$5.33K
JAMF
1682
DELISTED
Jamf
JAMF
$290K ﹤0.01%
+17,584
New +$308K
GRC icon
1683
Gorman-Rupp
GRC
$2.16B
$290K ﹤0.01%
7,892
-1,160
-13% -$41K
OSUR icon
1684
OraSure Technologies
OSUR
$273M
$289K ﹤0.01%
+67,773
New +$345K
GLSI icon
1685
Greenwich LifeSciences
GLSI
$191M
$287K ﹤0.01%
16,650
+5,285
+47% +$77.2K
HESM icon
1686
Hess Midstream
HESM
$5.22B
$287K ﹤0.01%
7,874
+436
+6% +$15.4K
NTIC icon
1687
Northern Technologies International Corp
NTIC
$76.4M
$285K ﹤0.01%
+17,216
New +$286K
ALTO icon
1688
Alto Ingredients
ALTO
$360M
$284K ﹤0.01%
196,832
-221,413
-53% -$383K
KGS icon
1689
Kodiak Gas Services
KGS
$5.96B
$284K ﹤0.01%
10,414
-3,414
-25% -$92.6K
HAFC icon
1690
Hanmi Financial
HAFC
$943M
$284K ﹤0.01%
16,962
-50,301
-75% -$784K
FSLY icon
1691
Fastly Inc
FSLY
$3.17B
$281K ﹤0.01%
38,186
+13,619
+55% +$133K
SAGE
1692
DELISTED
Sage Therapeutics
SAGE
$281K ﹤0.01%
+25,903
New +$332K
WT icon
1693
WisdomTree
WT
$2.97B
$281K ﹤0.01%
28,380
-9,304
-25% -$87.5K
AXTI icon
1694
AXT Inc
AXTI
$3.09B
$280K ﹤0.01%
82,709
-42,034
-34% -$147K
XLV icon
1695
State Street Health Care Select Sector SPDR ETF
XLV
$42.1B
$278K ﹤0.01%
1,907
+1,351
+243% +$194K
FITB
1696
Fifth Third Bancorp
FITB
$52B
$277K ﹤0.01%
7,602
-79,388
-91% -$2.9M
PRAX icon
1697
Praxis Precision Medicines
PRAX
$9.07B
$275K ﹤0.01%
6,658
-9,263
-58% -$438K
IMKTA icon
1698
Ingles Markets
IMKTA
$1.63B
$275K ﹤0.01%
4,013
-2,440
-38% -$177K
MRC
1699
DELISTED
MRC Global
MRC
$271K ﹤0.01%
20,979
-42,279
-67% -$529K
STR
1700
DELISTED
Sitio Royalties
STR
$270K ﹤0.01%
11,450
+1,660
+17% +$39K

Similar funds

Man Group's Q2 2024 Portfolio in Review

As of Q2 2024, Man Group held 2,343 positions worth $39.6B, down 0.17% from $39.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Man Group withdrew a net $1.56B in Q2 2024, closing 343 positions and reducing 773 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $92.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Man Group opened a new position in Masimo worth $36.7M.

  • Man Group's largest Q2 2024 buy was Masimo: 291,789 shares worth $36.7M.
  • Man Group added most to CRH in Q2 2024, an estimated $199M increase.
  • Man Group's biggest Q2 2024 reduction was TSMC, cutting an estimated $343M.
  • Man Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $92.5M.
  • Man Group's ten largest holdings make up 15% of its $39.6B portfolio in Q2 2024.
  • Man Group opened 235 new positions and closed 343 in Q2 2024.
  • Man Group's portfolio value fell 0.17% quarter-over-quarter to $39.6B.

Based on Man Group's 13F filing for Q2 2024, filed 14 Aug 2024.